Cargando…
Discovery of novel selective PI3Kγ inhibitors through combining machine learning-based virtual screening with multiple protein structures and bio-evaluation
INTRODUCTION: Phosphoinositide 3-kinase gamma (PI3Kγ) has been regarded as a promising drug target for the treatment of various diseases, and the diverse physiological roles of class I PI3K isoforms (α, β, δ, and γ) highlight the importance of isoform selectivity in the development of PI3Kγ inhibito...
Autores principales: | Zhu, Jingyu, Li, Kan, Xu, Lei, Cai, Yanfei, Chen, Yun, Zhao, Xinling, Li, Huazhong, Huang, Gang, Jin, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800018/ https://www.ncbi.nlm.nih.gov/pubmed/35127160 http://dx.doi.org/10.1016/j.jare.2021.04.007 |
Ejemplares similares
-
Integrating Machine Learning-Based Virtual Screening With Multiple Protein Structures and Bio-Assay Evaluation for Discovery of Novel GSK3β Inhibitors
por: Zhu, Jingyu, et al.
Publicado: (2020) -
Discovery of a novel phosphoinositide 3-kinase gamma (PI3Kγ) inhibitor against hematologic malignancies and theoretical studies on its PI3Kγ-specific binding mechanisms
por: Zhu, Jingyu, et al.
Publicado: (2019) -
Scoparone inhibits pancreatic cancer through PI3K/Akt signaling pathway
por: Li, Na, et al.
Publicado: (2021) -
MicroRNA-101 inhibits growth and metastasis of human ovarian cancer cells by targeting PI3K/AKT
por: Wei, Min, et al.
Publicado: (2019) -
Allosteric activation or inhibition of PI3Kγ mediated through conformational changes in the p110γ helical domain
por: Harris, Noah J, et al.
Publicado: (2023)